[1-[2-[(5-butylsulfanyl-1,3,4-thiadiazol-2-yl)amino]-2-oxoethyl]-1,2,4-triazol-4-ium-4-yl]-nitroazanide
-
[1-[2-[(5-butylsulfanyl-1,3,4-thiadiazol-2-yl)amino]-2-oxoethyl]-1,2,4-triazol-4-ium-4-yl]-nitroazanide
structure -
-
CAS No:
5613-01-4
-
Formula:
C10H14N8O3S2
-
Chemical Name:
[1-[2-[(5-butylsulfanyl-1,3,4-thiadiazol-2-yl)amino]-2-oxoethyl]-1,2,4-triazol-4-ium-4-yl]-nitroazanide
-
Synonyms:
5613-01-4;ZINC02905623;CBMicro_026019;DTXSID50367291;CCG-12912;STK673396;AKOS001716605;BIM-0025975.P001;SR-01000516540;SR-01000516540-1;[1-(2-{[5-(butylsulfanyl)-1,3,4-thiadiazol-2-yl]amino}-2-oxoethyl)-1H-1,2,4-triazol-4-ium-4-yl](nitro)azanide
-
CAS No:
[1-[2-[(5-butylsulfanyl-1,3,4-thiadiazol-2-yl)amino]-2-oxoethyl]-1,2,4-triazol-4-ium-4-yl]-nitroazanide Basic Attributes
358.4 g/mol
358.06302869 g/mol
DTXSID50367291
Computed Properties
Molecular Weight:358.4
XLogP3:2.6
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:9
Rotatable Bond Count:8
Exact Mass:358.06302869
Monoisotopic Mass:358.06302869
Topological Polar Surface Area:177
Heavy Atom Count:23
Complexity:412
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Request for Quotation